Boothbay Fund Management, LLC Abb Vie Inc. Call Options Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $3.57 Million - $4.13 Million	26,700 New	26,700 $3.98 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $15.2 Million - $18.2 Million	-110,000 Reduced 75.76%	35,200 $5.69 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $19.1 Million - $21.9 Million	142,200 Added 4740.0%	145,200 $19.5 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $743,148 - $944,784	-5,400 Reduced 64.29%	3,000 $459,000
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $1.11 Million - $1.38 Million	8,400 New	8,400 $1.36 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.